article thumbnail

Company profile: NeoImmuneTech

pharmaphorum

Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy. T cells are known to mediate anti-tumor immune responses. For that reason, they have become the key target of immune checkpoint therapies, like PD-(L)1 agents. Creation: Jan. Areas of expertise: Immuno-Oncology.

article thumbnail

Drug Allergy

RX Note

Is the reaction due to an immune response to the drug (i.e. Drug allergy refers to adverse drug reactions due to hypersensitivity that mediates a specific immune response directed at the drug. NOTE: It is often difficult to distinguish between allergy and non-immune drug hypersensitivity reaction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Navigating Life’s Challenges: A Pharmacist’s Transformative Journey of Dedication and Compassion

Pharmacy Is Right For Me

Commencing her journey towards becoming a pharmacist at Rosalind Franklin University of Medicine and Science in 2014, she initially hesitated about working in a community pharmacy setting.

article thumbnail

Drug Allergy

RX Note

Is the reaction due to an immune response to the drug (i.e. Drug allergy refers to adverse drug reactions due to hypersensitivity that mediates a specific immune response directed at the drug. NOTE: It is often difficult to distinguish between allergy and non-immune drug hypersensitivity reaction.

article thumbnail

Turmeric for Your Thyroid and Hashimoto’s

The Thyroid Pharmacist

2014 Jul;69:182-201 [2] Prasad S, Aggarwal BB. 2014 Jul;69:182-201 [15] Prasad S, Aggarwal BB. 2014 Apr;10(38):106-10 [18] Bright JJ. 2014 Jul;69:182-201 [20] Kress, R. 2014 Jan; 46(1): 2–18. [22] Nutr J 13, 11 (2014). 2014 Jan; 46(1): 2–18. [24] Food Chem Toxicol. Mol Med Rep. 2019;20(3):2332-2338.

Dosage 98
article thumbnail

AbbVie, Calico raise their age-related disease alliance funding to $3.5bn

pharmaphorum

The collaboration with Google sister company Calico – formed in 2014 with $1.5 The clinical-stage projects include two immuno-oncology candidates in phase 1 testing – both PTPN2 inhibitors – that “act at multiple steps in the cancer immunity cycle”, and a drug for a neurodegenerative disease, according to a February update.

article thumbnail

AstraZeneca acquires TeneoTwo in $1.3bn deal to broaden haematology portfolio

Pharmaceutical Technology

Moreover, a deeper understanding of immune evasion by cancer cells may provide novel sensitization strategies to further enhance the clinical response of BiTEs. .